Data as of Nov 26
| +3.19 / +9.04%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 48.00, with a high estimate of 55.00 and a low estimate of 36.00. The median estimate represents a +24.77% increase from the last price of 38.47.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.